Patent · US Active

C5aR antagonists

US8445515B2 · kind B2 · utility

30Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2009
Grant dateMay 21, 2013
Priority date
Expiry dateFeb 3, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.